Skip to main content
. 2013 Jun 1;4:72. doi: 10.4103/2152-7806.112822

Figure 2.

Figure 2

Epidermal growth factor receptor and platelet-derived growth factor receptor signaling pathways in chordoma mediated by tyrosine kinases and downstream effectors. These molecules are potential therapeutic targets of targeted inhibition by cetuximab, erlotinib, gefitinib, imatinib, PI-103, and rapamycin analogs